Advertisement
IPST vs NMR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPST is a Hold and NMR is a Buy.
Momentum Indicator for IPST turns negative, indicating new downward trend
IPST saw its Momentum Indicator move below the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator turned negative. In 33 of the 33 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for IPST entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IPST's RSI Indicator exited the oversold zone, 14 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for IPST just turned positive on October 27, 2026. Looking at past instances where IPST's MACD turned positive, the stock continued to rise in 10 of 11 cases over the following month. The odds of a continued upward trend are 90%.
Following a +2.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPST advanced for three days, in 61 of 73 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
IPST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.048) is normal, around the industry mean (3.120). P/E Ratio (-0.007) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. P/S Ratio (0.134) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. IPST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
NMR's RSI Oscillator climbs out of oversold territory
The RSI Indicator for NMR moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 18 of the 25 cases the stock moved higher. This puts the odds of a move higher at 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on NMR as a result. In 56 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for NMR just turned positive on October 29, 2026. Looking at past instances where NMR's MACD turned positive, the stock continued to rise in 33 of 48 cases over the following month. The odds of a continued upward trend are 69%.
Following a +3.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where NMR advanced for three days, in 206 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 56 cases where NMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
NMR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NMR entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 14 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.007) is normal, around the industry mean (3.120). P/E Ratio (0.068) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.815) is also within normal values, averaging (0.809). Dividend Yield (0.041) settles around the average of (8.976) among similar stocks. P/S Ratio (2.472) is also within normal values, averaging (16.899).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
NMR | ||
|---|---|---|
OUTLOOK RATING 1..100 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 14 | |
SMR RATING 1..100 | 1 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 97 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| IPST | NMR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | 1 day ago 72% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 55% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 68% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 69% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 55% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 63% |
| Advances ODDS (%) | 14 days ago 84% | 14 days ago 68% |
| Declines ODDS (%) | 1 day ago 90% | 6 days ago 55% |
| BollingerBands ODDS (%) | 1 day ago 69% | 1 day ago 52% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 59% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IPST’s FA Score shows that 0 FA rating(s) are green while NMR’s FA Score has 2 green FA rating(s).
- IPST’s FA Score: 0 green, 5 red.
- NMR’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IPST’s TA Score shows that 5 TA indicator(s) are bullish while NMR’s TA Score has 4 bullish TA indicator(s).
- IPST’s TA Score: 5 bullish, 3 bearish.
- NMR’s TA Score: 4 bullish, 4 bearish.
Price Growth
IPST (@Investment Banks/Brokers) experienced а -14.90% price change this week, while NMR (@Investment Banks/Brokers) price change was +0.42% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -3.40%. For the same industry, the average monthly price growth was -18.39%, and the average quarterly price growth was -23.03%.
Reported Earning Dates
IPST is expected to report earnings on Nov 16, 2026.
NMR is expected to report earnings on Feb 03, 2027.
Industries' Descriptions
@Investment Banks/Brokers (-3.40% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
Advertisement
IPST and
Correlation & Price change
A.I.dvisor tells us that IPST and BGDE have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPST and BGDE's prices will move in lockstep.
| Ticker / NAME | Correlation To IPST | 1D Price Change % | ||
|---|---|---|---|---|
| IPST | 100% | -3.23% | ||
| BGDE - IPST | 24% Poorly correlated | -4.38% | ||
| HOOD - IPST | 21% Poorly correlated | +4.00% | ||
| SLNH - IPST | 20% Poorly correlated | +10.68% | ||
| PWCM - IPST | 20% Poorly correlated | +2.81% | ||
| NMR - IPST | 20% Poorly correlated | +1.89% | ||
More | ||||
NMR and
Correlation & Price change
A.I.dvisor indicates that over the last year, NMR has been loosely correlated with MS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NMR jumps, then MS could also see price increases.